159 related articles for article (PubMed ID: 21344240)
21. Novel and reported variants in Parkinson's disease genes confer high disease burden among Indians.
Kumar S; Yadav N; Pandey S; Muthane UB; Govindappa ST; Abbas MM; Behari M; Thelma BK
Parkinsonism Relat Disord; 2020 Sep; 78():46-52. PubMed ID: 32707456
[TBL] [Abstract][Full Text] [Related]
22. A systematic screening to identify de novo mutations causing sporadic early-onset Parkinson's disease.
Kun-Rodrigues C; Ganos C; Guerreiro R; Schneider SA; Schulte C; Lesage S; Darwent L; Holmans P; Singleton A; ; Bhatia K; Bras J
Hum Mol Genet; 2015 Dec; 24(23):6711-20. PubMed ID: 26362251
[TBL] [Abstract][Full Text] [Related]
23. The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.
Thaler A; Ash E; Gan-Or Z; Orr-Urtreger A; Giladi N
J Neural Transm (Vienna); 2009 Nov; 116(11):1473-82. PubMed ID: 19756366
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.
Johnson J; Paisán-Ruíz C; Lopez G; Crews C; Britton A; Malkani R; Evans EW; McInerney-Leo A; Jain S; Nussbaum RL; Foote KD; Mandel RJ; Crawley A; Reimsnider S; Fernandez HH; Okun MS; Gwinn-Hardy K; Singleton AB
Neurodegener Dis; 2007; 4(5):386-91. PubMed ID: 17622782
[TBL] [Abstract][Full Text] [Related]
25. Genetic analysis of the ATG16L1 gene promoter in sporadic Parkinson's disease.
Wang L; Huang J; Pang S; Qin X; Qi Z; Hawley RG; Yan B
Neurosci Lett; 2017 Apr; 646():30-35. PubMed ID: 28279708
[TBL] [Abstract][Full Text] [Related]
26. GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson's disease: a two-cohort case-control study.
Pan HX; Zhao YW; Mei JP; Fang ZH; Wang Y; Zhou X; Zhou YJ; Zhang R; Zhang KL; Jiang L; Zeng Q; He Y; Wang Z; Liu ZH; Xu Q; Sun QY; Yang Y; Hu YC; Chen YS; Du J; Lei LF; Zhang HN; Wang CY; Yan XX; Shen L; Jiang H; Tan JQ; Li JC; Tang BS; Guo JF
Transl Neurodegener; 2020 Aug; 9(1):31. PubMed ID: 32746945
[TBL] [Abstract][Full Text] [Related]
27. Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?
Biernacka JM; Armasu SM; Cunningham JM; Ahlskog JE; Chung SJ; Maraganore DM
Parkinsonism Relat Disord; 2011 Dec; 17(10):730-6. PubMed ID: 21816655
[TBL] [Abstract][Full Text] [Related]
28. Non-synonymous GIGYF2 variants in Parkinson's disease from two Asian populations.
Tan EK; Lin CH; Tai CH; Tan LC; Chen ML; Li R; Lim HQ; Pavanni R; Yuen Y; Prakash KM; Zhao Y; Wu RM
Hum Genet; 2009 Sep; 126(3):425-30. PubMed ID: 19449032
[TBL] [Abstract][Full Text] [Related]
29. Common variants in PARK loci and related genes and Parkinson's disease.
Chung SJ; Armasu SM; Biernacka JM; Lesnick TG; Rider DN; Lincoln SJ; Ortolaza AI; Farrer MJ; Cunningham JM; Rocca WA; Maraganore DM
Mov Disord; 2011 Feb; 26(2):280-8. PubMed ID: 21412835
[TBL] [Abstract][Full Text] [Related]
30. Identification of three novel LRRK2 mutations associated with Parkinson's disease in a Calabrian population.
Anfossi M; Colao R; Gallo M; Bernardi L; Conidi ME; Frangipane F; Vasso F; Puccio G; Clodomiro A; Mirabelli M; Curcio SA; Torchia G; Smirne N; Di Lorenzo R; Maletta R; Bruni AC
J Alzheimers Dis; 2014; 38(2):351-7. PubMed ID: 23963289
[TBL] [Abstract][Full Text] [Related]
31. Association of polymorphisms and reduced expression levels of the NR4A2 gene with Parkinson's disease in a Mexican population.
Ruiz-Sánchez E; Yescas P; Rodríguez-Violante M; Martínez-Rodríguez N; Díaz-López JN; Ochoa A; Valdes-Rojas SS; Magos-Rodríguez D; Rojas-Castañeda JC; Cervantes-Arriaga A; Canizales-Quinteros S; Rojas P
J Neurol Sci; 2017 Aug; 379():58-63. PubMed ID: 28716280
[TBL] [Abstract][Full Text] [Related]
32. Utility and implications of exome sequencing in early-onset Parkinson's disease.
Trinh J; Lohmann K; Baumann H; Balck A; Borsche M; Brüggemann N; Dure L; Dean M; Volkmann J; Tunc S; Prasuhn J; Pawlack H; Imhoff S; Lill CM; Kasten M; Bauer P; Rolfs A; ; Klein C
Mov Disord; 2019 Jan; 34(1):133-137. PubMed ID: 30537300
[TBL] [Abstract][Full Text] [Related]
33. Gene Panel Sequencing Identifies Novel Pathogenic Mutations in Moroccan Patients with Familial Parkinson Disease.
Smaili I; Tesson C; Regragui W; Bertrand H; Rahmani M; Bouslam N; Benomar A; Brice A; Lesage S; Bouhouche A
J Mol Neurosci; 2021 Jan; 71(1):142-152. PubMed ID: 32557143
[TBL] [Abstract][Full Text] [Related]
34. A computational system to select candidate genes for complex human traits.
Gaulton KJ; Mohlke KL; Vision TJ
Bioinformatics; 2007 May; 23(9):1132-40. PubMed ID: 17237041
[TBL] [Abstract][Full Text] [Related]
35. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece.
Kalinderi K; Bostantjopoulou S; Paisan-Ruiz C; Katsarou Z; Hardy J; Fidani L
Neurosci Lett; 2009 Mar; 452(2):87-9. PubMed ID: 19383421
[TBL] [Abstract][Full Text] [Related]
36. Novel and functional ATG12 gene variants in sporadic Parkinson's disease.
Li Y; Huang J; Pang S; Wang H; Zhang A; Hawley RG; Yan B
Neurosci Lett; 2017 Mar; 643():22-26. PubMed ID: 28229934
[TBL] [Abstract][Full Text] [Related]
37. Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson's disease.
Schulte EC; Mollenhauer B; Zimprich A; Bereznai B; Lichtner P; Haubenberger D; Pirker W; Brücke T; Molnar MJ; Peters A; Gieger C; Trenkwalder C; Winkelmann J
Neurogenetics; 2012 Aug; 13(3):281-5. PubMed ID: 22707335
[TBL] [Abstract][Full Text] [Related]
38. DNAJC13 mutation screening in patients with Parkinson's disease from South Italy.
Gagliardi M; Annesi G; Procopio R; Morelli M; Iannello G; Bonapace G; Mancini M; Nicoletti G; Quattrone A
Parkinsonism Relat Disord; 2018 Oct; 55():134-137. PubMed ID: 29887357
[TBL] [Abstract][Full Text] [Related]
39. Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage.
Shi C; Zheng Z; Wang Q; Wang C; Zhang D; Zhang M; Chan P; Wang X
PLoS One; 2016; 11(6):e0155758. PubMed ID: 27299523
[TBL] [Abstract][Full Text] [Related]
40. Parkinson's disease candidate gene prioritization based on expression profile of midbrain dopaminergic neurons.
Vahedi S; Rajabian M; Misaghian A; Grbec D; Simon HH; Alavian KN
J Biomed Sci; 2010 Aug; 17(1):66. PubMed ID: 20716345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
